FDA - According to an FDA Recall Update, Nostrum Laboratories, Inc. expended its nationwide recall of its Metformin HCl Extended-Release Tablets, USP 750 mg, on January 25, 2021. The reason for the recall is due to the unsafe, higher than Acceptable Daily Intake (ADI) amount of N-Nitrosodimethylamine (NDMA). The maximum allowable … [Read more...]